In other words Amgen cuts jobs by 12-14 percent. Pre-Tax restructuring charges of $600 million - $700 million is anticipated. Changes adjusted earnings guidance for 2007 from $4.28 to a range of $4.13 - $4.23 per share.

A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline

After years of frustration with traditional methods for testing the toxicity of chemicals in the environment, scientists are working to adapt faster, simpler screening methods that do not require animals, now used by the pharmaceutical industry to identify potential drug candidates, according to an article [insert link here] scheduled for the August 6 issue of Chemical & Engineering News (C&EN), ACS’s weekly newsmagazine.

Merck & Co., Inc. announced on July 24 second-quarter 2007 results that reflected an increase in earnings per share of 12% fueled by strong performance across a broad range of the Company's products.

Roche (SWX: ROG.VX; RO.S), a world-leading healthcare provider of pharmaceuticals and diagnostics, will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems Inc. (Nasdaq: VMSI) for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.

A growing number of critics are calling for stricter regulation of the pharmaceutical industry and how drugs are sold in the United States. The concern comes from medical experts, consumer groups and even from within the government agency in charge of the drug approval process.

Abbott was recently named among The Scientist magazine's "Best Places to Work in Industry" for the fifth year in a row. This prestigious list is based on a detailed survey of scientists at a cross-section of companies and research institutions nationwide.

According to the prescription drug bill passed by the senat today, FDA will be required to monitor the pharmaceutical companies and the medications they make three years after the drugs are approved. This is a very significant move by the Senat to helping FDA to ensure the safety of prescription drugs.

Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.

Drug Compliance Programs Demand Market Research Support